TGTX Net Income Growth
Tg Therapeutics Inc · Net Income Growth
TGTX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported630.24%period ending
TGTX TTM Net Income YoY % (-40.54% → 630.24%)
Year-over-year change
High-resolution chart · PNG
TGTX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 630.2425% | |
| 1,079.811% | |
| 1,812.4107% | |
| 3,215.2395% | |
| -36.8163% | |
| -4.9688% | |
| 84.5249% | |
| 44.5534% | |
| 154.4741% | |
| 124.4414% | |
| 106.3892% | |
| 89.1461% | |
| 39.1143% | |
| 48.3731% | |
| 43.0236% | |
| 30.4102% | |
| 16.2575% | |
| -2.3807% | |
| -24.5969% | |
| -48.6474% | |
| -67.642% | |
| -68.8784% | |
| -61.6134% | |
| -23.2823% | |
| -29.0998% | |
| -12.9981% | |
| 0.3528% | |
| -24.3732% | |
| -7.5058% | |
| -26.3321% | |
| -46.428% | |
| -35.2154% | |
| -41.5742% | |
| -43.5743% | |
| -51.4014% | |
| -54.162% | |
| -71.4087% | |
| -48.0752% | |
| -24.3123% | |
| -12.5634% | |
| 10.177% | |
| 0.9428% | |
| -12.8491% | |
| -50.3757% | |
| -128.3026% | |
| -157.9343% | |
| -172.3933% | |
| -133.3834% | |
| -83.8904% | |
| -111.9351% | |
| -13.3101% | |
| -15.9218% | |
| -16.7932% | |
| 23.0987% | |
| -2,018.5406% | |
| -2,476.4971% | |
| -1,202.7158% | |
| -345.378% | |
| -236.7884% | |
| 1,768.4995% | |
| 397.8231% | |
| 266.1623% | |
| 122.3266% | |
| 101.453% | |
| 87.6713% | |
| -6.1789% | |
| 34.26% | |
| 61.0942% | |
| 54.7128% | |
| 68.7022% | |
| 64.6867% | |
| 52.6258% | |
| 39.4829% | |
| -11.827% | |
| -18.9908% | |
| -39.1788% | |
| -32.2529% | |
| 51.9667% | |
| 47.1714% | |
| 48.0784% | |
| 49.5899% | |
| -229.7044% | |
| -224.6421% | |
| -224.073% | |
| -178.6806% | |
| 6.143% | |
| 1.0884% | |
| -17.3928% | |
| -211.7625% | |
| -393.3284% | |
| -285.3366% | |
| -176.901% | |
| -14.0067% | |
| 66.7614% | |
| 10.8367% | |
| -13.5025% | |
| -6.7441% | |
| -47.8052% | |
| 70.0999% | |
| 74.5903% |